Peter Atadja

Insider Reports History

Location
Newtown, PA
Signature
/s/ Mark Guerin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Atadja:

Company Role Class Num Shares Value Price $ Report Date Ownership
Onconova Therapeutics, Inc. Director Stock Option (right to purchase) 66,468 10 Aug 2023 Direct

Insider Reports Filed by Peter Atadja

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRAW Onconova Therapeutics, Inc. 10 Aug 2023 1 $0 4 Director 14 Aug 2023, 17:49
TRAW Onconova Therapeutics, Inc. 15 Dec 2022 1 $0 4 Director 19 Dec 2022, 17:56
TRAW Onconova Therapeutics, Inc. 15 Dec 2022 0 $0 3 Director 19 Dec 2022, 17:50